What's new

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 4, Status: Authorised

Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 4, Status: Authorised

Apr 8, 2025 - 15:12
 0
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 4, Status: Authorised
Human medicines European public assessment report (EPAR): Enspryng, satralizumab, Date of authorisation: 24/06/2021, Revision: 4, Status: Authorised
Read More

Tags:

Previous Article

Filthy Coffee Maker at Hyatt. Stained Sheets at Westin. What’s Lurking in Your H...

Next Article

UK’s Red Arrows Join Italy’s Frecce Tricolori In Historic Rome Flyover

Related Posts

2024 European Medicines Agency annual report on indepen...

Mar 19, 2025  0

Human medicines European public assessment report (EPAR): Inrebic, fedratinib, Date of authorisation: 08/02/2021, Revision: 7, Status: Authorised

Human medicines European public assessment report (EPAR...

Mar 5, 2025  0

Minutes - PDCO minutes of the 28-31 January 2025 meeting

Mar 12, 2025  0